LeukoVantage®, Myeloproliferative Neoplasms (MPN)
Test Code
Clinical Significance
LeukoVantage®, Myeloproliferative Neoplasms (MPN) - This test is designed to aid in diagnosis, prognosis and/or treatment strategy for patients with MPN.
Test Resources
Test Details
Methodology
Reference Range(s)
Alternative Name(s)
Preferred Specimen(s)
5 mL whole blood or bone marrow collected in an EDTA (lavender-top) tube
Alternative Specimen(s)
Whole blood or bone marrow collected in: Sodium heparin (green-top) tube • 50 uL of 10 ng/uL extracted DNA in microcentrifuge tube • Fixed pellet collected in a sterile leak-proof container
Minimum Volume
2 mL whole blood or bone marrow • 20 uL of 10 ng/uL extracted DNA
Collection Instructions
Requisition form and Pathology/Flow Cytometry Reports are required. In addition, only accept extracted DNA when extraction or isolation is performed in an appropriately qualified laboratory such as a CLIA certified laboratory or a laboratory meeting equivalent requirements as determined by the CAP and/or CMS.
Transport Container
EDTA (lavender-top) tube
Transport Temperature
Room temperature
Specimen Stability
- Whole blood and bone marrow (EDTA)
- Room temperature: 14 days
- Refrigerated: 14 days
- Frozen: Unacceptable
- Whole blood and bone marrow (Sodium heparin)
- Room temperature: 7 days
- Refrigerated: 7 days
- Frozen: Unacceptable
- Extracted DNA
- Room temperature: 30 days
- Refrigerated: 2 years
- Frozen: Indefinite
- Celle pellet
- Room temperature: 7 days
- Refrigerated: 7 days
- Frozen: Unacceptable
Reject Criteria
Gross hemolysis • Frozen • Clotted
Setup Schedule
Room temperature: 14 days
Refrigerated: 14 days
Frozen: Unacceptable
Whole blood and bone marrow (Sodium heparin)
Room temperature: 7 days
Refrigerated: 7 days
Frozen: Unacceptable
Extracted DNA
Room temperature: 30 days
Refrigerated: 2 years
Frozen: Indefinite
Celle pellet
Room temperature: 7 days
Refrigerated: 7 days
Frozen: Unacceptable